Education
About Us
Working with TipRanks
Follow Us
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.41T | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 57.20B | $ -113.86K | $ -44.19K | $ -204.69K | $ -262.14K |
| Operating Income | $ -67.06T | $ -71.70M | $ -53.13M | $ -63.07M | $ -51.73M |
| EBITDA | $ -67.06T | $ -72.09M | $ -57.38M | $ -64.36M | $ -51.51M |
| Net Income | $ -62.42T | $ -75.37M | $ -58.98M | $ -66.05M | $ -53.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.08T | $ 14.93M | $ 23.39M | $ 17.40M | $ 14.48M |
| Total Assets | $ 18.58T | $ 28.82M | $ 32.30M | $ 28.53M | $ 22.81M |
| Total Debt | $ 247.70B | $ 29.74M | $ 35.56M | $ 10.96M | $ 11.90M |
| Net Debt | $ -7.84T | $ 14.81M | $ 12.16M | $ -6.44M | $ -2.57M |
| Total Liabilities | $ 50.77T | $ 101.90M | $ 46.74M | $ 19.79M | $ 18.20M |
| Stockholders' Equity | $ -32.19T | $ -73.08M | $ -14.44M | $ 8.74M | $ 4.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.83T | $ -68.79M | $ -42.97M | $ -56.67M | $ -54.25M |
| Operating Cash Flow | $ -51.83T | $ -68.79M | $ -42.97M | $ -56.67M | $ -54.25M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 44.98T | $ 60.33M | $ 48.97M | $ 59.59M | $ 56.19M |